Xenon versus Desflurane anesthesia during cardioverter defribrillator implantation.

Comparative study between xenon anaesthesia and desflurane anaesthesia in patients with severely decreased left ventricular function, undergoing cardioverter defribrillator implantation.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON22512

Enrollment

Registered

2011-05-17

Start date

2011-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

decreased left ventricular function, cardioverter defribrillator, echocardiography

Interventions

Xenon versus Desflurane anesthesia monitored by TOE.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients scheduled for internal cardioverter defibrillator implantation; 2. A preoperative left ventricular ejection fraction 17 y; 4. Planned surgery < 2 h.

Exclusion criteria

Exclusion criteria: 1. Patients with COPD, myocardial infarction < 3 m before surgery; 2. Withdrawal from the study is performed whenever a serious adverse event (e.g. major bleeding, shock or death) occurs.

Design outcomes

Primary

Measure	Time frame
LV systolic function and contractility will be assessed.	—

Secondary

Measure	Time frame
Postoperative problems, such as nausea, vomiting, changes of haemodynamics 20 % beyond baseline measurements, or hypoxia will be reported. Also postoperative nausea and vomiting, shivering dizziness, confusion etc. are stated as adverse events.	—

Contacts

Public ContactVeerle Mossevelde, van

Laarbeeklaan 101

veerle.vanmossevelde@uzbrussel.be+32 (0)2 4763134

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)